Spontaneous pneumothorax secondary to sunitinib, a vascular endothelial growth factor receptor (VEGFR) inhibitor, is an extremely rare side effect of this class of medications. In this report, we present the case of a patient with metastatic renal cell carcinoma (RCC) who developed bilateral pneumothoraces after starting on sunitinib. This case report recognizes pneumothorax as a life-threatening side effect of sunitinib.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7478553 | PMC |
| http://dx.doi.org/10.7759/cureus.9586 | DOI Listing |
Publication Analysis
Top Keywords
patient metastatic
8
renal cell
8
cell carcinoma
8
sunitinib
4
sunitinib unusual
4
unusual pneumothorax
4
pneumothorax patient
4
metastatic chromophobe
4
chromophobe renal
4
carcinoma spontaneous
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!